FDA-regulated cGMP synthesis requires significant analytical and quality control support. ChemPacific maintains well-equipped and experienced analytical chemistry resources, providing state-of-the-art analytical method development, structure elucidation, physical characterization, and the ability to handle challenging analytical compounds.

ChemPacific has filed for 15 DMF’s (Drug Master Files) and 12 patents since inception. Our US facility has received an EIR (Establishment Inspection Report) letter 7 times since 2002 (last one in May 2024), and our China plant has received an EIR letter 4 times since 2008. Our advanced technologies have warranted a leading role in the supply of APIs, API intermediates and other cGMP services.

ChemPacific produces APIs specifically for customers under IP protection. However, Norepinephrine Bitartrate and Dyclonine are made at our Baltimore facility in the US, sold directly by ChemPacific and shipped to various countries all over the globe.

Norepinephrine Bitartrate, CAS 69815-49-2

Dyclonine HCl, CAS 536-43-6

ChemPacific is also able to offer new compounds for pre-clinical, phase 1 (IND) all the way to NDA filing. For pricing or more information, please refer to our CONTACT US page.